<DOC>
	<DOCNO>NCT02577848</DOCNO>
	<brief_summary>The investigator plan evaluate effect liraglutide leave ventricular function patient non-ST-segment elevation myocardial infarction ( NSTEMI ) .</brief_summary>
	<brief_title>GLP-1 Non-ST-Segment Elevation Myocardial Infarction</brief_title>
	<detailed_description>Patients non-ST-segment elevation myocardial infarction ( NSTEMI ) heterogeneous group respect risk major adverse cardiac event ( MACE ) . Elevation blood glucose common metabolic disorder among patient acute myocardial infarction ( AMI ) associate adverse prognosis . Glucagon-like peptide-1 ( GLP-1 ) incretin hormone regulate plasma glucose . GLP-1 analogue significant cardiovascular protective effect patient AMI . GLP-1 may antioxidant anti-inflammatory property , protect endothelial function . Studies conscious , chronically instrumented dog demonstrate GLP-1 infusion increase insulin sensitivity myocardial glucose uptake postischemic contractile dysfunction dilate cardiomyopathy . Liraglutide , GLP-1 analogue , report reduce cardiac rupture infarct size improve cardiac output normal diabetic mouse . Continuous infusion GLP-1 ( 1.5 pmol/kg/min ) show improve functional recovery patient AMI complicate decreased leave ventricular function GLP-1 could protect ischemia-reperfusion injury improve cardiac function patient acute ST-segment elevation myocardial infarction . However , effect GLP-1 NSTEMI patient remain unclear . The aim study evaluate effect liraglutide leave ventricular function patient NSTEMI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<criteria>nonSTsegment elevation myocardial infarction ( NSTEMI ) 1. unconscious presentation 2. STsegment elevation acute myocardial infarction 3 . NSTEMI require emergency percutaneous coronary angiography 4. valvular heart disease 5. cardiogenic shock 6. hypoglycaemia 7. diabetic ketoacidosis 8. history myocardial infarction 9. stent implantation 10. renal insufficiency 11. previously undergone coronary artery bypass surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Glucagon-like peptide-1</keyword>
	<keyword>Non-ST-segment elevation myocardial infarction</keyword>
	<keyword>Left ventricular ejection fraction</keyword>
</DOC>